Pathogenic hyperactivation of mTORC1 by cytoplasmic EP300 in Hutchinson-Gilford progeria syndrome

Lucille Ferret; Guido Guido Kroemer; Mojgan Djavaheri‐Mergny

doi:10.15698/cst2024.04.295

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2012

Aberrant DNA methylation profiles in the premature aging disorders Hutchinson-Gilford Progeria and Werner syndrome

Holger Heyn, Sebastián Morán, Manel Esteller

Article2022

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

Valentina Fanny Leone, Amantia Imeraj, Sara Gastoldi, Caterina Mele, Lucia Liguori, Carmelita Condemi, Piero Ruggenenti, Giuseppe Remuzzi, Camillo Carrara

Article2024

Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing’s syndrome

Hui Pan, Ai-Ling Tian, Hui Chen, Yi-Fan Xia, Allan Sauvat, Stéphanie Moriceau, Flavia Lambertucci, Omar Motiño, Liwei Zhao, Peng Liu, Misha Mao, S N Li, Shuai Zhang, Adrien Joseph, Sylvère Durand, Fanny Aprahamian, Zeyu Luo, Yang Ou, Zhe Shen, Enfu Xue, Yuhong Pan, Vincent Carbonnier, Gautier Stoll, Sabrina Forveille, Marion Leduc, Giulia Cerrato,

Article2007

Complement hyperactivation may cause atypical haemolytic uraemic syndrome gain-of-function mutations in factor B

Jessica Caprioli, Giuseppe Remuzzi

Article2018

Methionine restriction for improving progeria: another autophagy-inducing anti-aging strategy?

Clea Bárcena, Carlos López-Otı́n, Guido Guido Kroemer